Ex vivo susceptibility to new antimalarial agents differs among human-infecting Plasmodium species

Several promising antimalarial drugs are currently being tested in human trials, such as artefenomel, cipargamin, ferroquine and ganaplacide. Many of these compounds were identified using high throughput screens against a single species of human malaria, Plasmodium falciparum, under the assumption t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Parasitol Drugs Drug Resist
Hlavní autoři: van Schalkwyk, Donelly A., Moon, Robert W., Duffey, Maëlle, Leroy, Didier, Sutherland, Colin J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
Regular article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327131/
https://ncbi.nlm.nih.gov/pubmed/34315108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.07.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky